actin-binding fragment is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-05. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | N-terminal fragment of thymosin beta-4 |
| Residue count | Seven | Sequence LKKTETQ |
| Approximate mass | 889 Da | Acetylated seven-residue peptide |
| Common synonyms | TB4 fragment, TB500 | Not identical to full-length TB4 |
| Reported activity | Actin binding | Observed mainly in cell-free systems |
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
=== AFL policy === The AFL is a signatory to ASADA and WADA, and its policy on performance-enhancing drugs is based upon those organisations. For non-performance-enhancing drugs, the AFL currently has a "three-strikes" policy, under which only the player and the club doctor are aware of any positive tests until a third such test is received. After the third strike, the club is made aware of the situation and the player may face disciplinary action. This policy has faced criticism for leniency from anti-doping bodies, particularly the World Anti-Doping Agency (WADA), and as such has attracted much media scrutiny and public debate.
The technique was first described by Semisotnov et al. (1991) using 1,8-ANS and quartz cuvettes. 3 Dimensional Pharmaceuticals were the first to describe a high-throughput version using a plate reader and Wyeth Research published a variation of the method with SYPRO Orange instead of 1,8-ANS. SYPRO Orange has an excitation/emission wavelength profile compatible with qPCR machines which are almost ubiquitous in institutions that perform molecular biology research. The name differential scanning fluorimetry (DSF) was introduced later but Thermofluor is preferable as Thermofluor is no longer trademarked and differential scanning fluorimetry is easily confused with differential scanning calorimetry. SYPRO Orange binds nonspecifically to hydrophobic surfaces, and water strongly quenches its fluorescence. When the protein unfolds, the exposed hydrophobic surfaces bind the dye, resulting in an increase in fluorescence by excluding water. Detergent micelles will also bind the dye and increase background noise dramatically. This effect is lessened by switching to the dye ANS; however, this reagent requires UV excitation. The stability curve and its midpoint value (melting temperature, Tm also known as the temperature of hydrophobic exposure, Th) are obtained by gradually increasing the temperature to unfold the protein and measuring the fluorescence at each point. Curves are measured for protein only and protein + ligand, and ΔTm is calculated.
=== Paul trap === A Paul trap (also known as a quadrupole ion trap) uses static direct current (DC) and radio frequency (RF) oscillating electric fields to trap ions. Paul traps are commonly used as components of mass spectrometers. Wolfgang Paul invented the Paul trap, hence its name. For this work he shared the 1989 Nobel Prize in Physics.
== Chemistry == Flmodafinil is a racemic mixture of (S)-(+)- and (R)-(–)-enantiomers. The (S)-(+) enantiomer has been referred to as JBG1-048 and the (R)-(–) enantiomer has been referred to as JBG1-049.
The Claisen-Schmidt condensation between 3-(methoxymethoxy)benzaldehyde [13709-05-2] (1) and cyclohexanone (2) afforded CID:54364197 (3). Michael addition of dimethylamine leads the aminoketone, i.e. 2-[dimethylamino-[3-(methoxymethoxy)phenyl]methyl]cyclohexan-1-one, CID21518320. Reduction of the ketone proceeds stereospecifically to afford the cis aminoalcohol [51356-58-2] (4). Mild hydrolysis of the product gives the free phenol ciramadol (5).
Sources: en.wikipedia.org
I think at the end of the day, it's really, really early. And we feel that. And I think other brands feel that, too." Taco Bell stated that it was seeking to address the situation with a "hybrid approach."
While Waglerin-1 interacts with other members of the ligand-gated superfamily of ion channels, the potency is much less than for inhibition of the adult mouse muscle acetylcholine receptor. Structural study suggests that Waglerin-1 may undergo molecular rearrangement that allows for binding to multiple receptors. The actions of Waglerin-1 reverse upon removal of the peptide. Waglerin-1 is included in some skin creams marketed as wrinkle removers. There is no scientific evidence supporting the manufacturers' suggestion that the Waglerin-1 included in their products relaxes wrinkle producing skeletal muscles.
== Further reading == Mullbacher A, Waring P, Eichner RD (1985). "Identification of an Agent in Cultures of Aspergillus fumigatus Displaying Anti-phagocytic and Immunomodulating Activity in vitro". Microbiology. 131 (5): 1251–1258. doi:10.1099/00221287-131-5-1251. PMID 2410548. Shah DT, Larsen B (1991). "Clinical isolates of yeast produce a gliotoxin-like substance". Mycopathologia. 116 (3): 203–208. doi:10.1007/BF00436836. PMID 1724551. S2CID 12919491. Jones RW, Hancock JG (1988). "Mechanism of Gliotoxin Action and Factors Mediating Gliotoxin Sensitivity". Microbiology. 134 (7): 2067–2075. doi:10.1099/00221287-134-7-2067. Schweizer M, Richter C (1994). "Gliotoxin Stimulates Ca2+ Release from Intact Rat Liver Mitochondria". Biochemistry. 33 (45): 13401–13405. doi:10.1021/bi00249a028. PMID 7524661. Scharf DH, Brakhage AA, Mukherjee PK (2016). "Gliotoxin - bane or boon?". Environmental Microbiology. 18 (4): 1096–1109. Bibcode:2016EnvMi..18.1096S. doi:10.1111/1462-2920.13080. PMID 26443473. Puri A, Ahmad A, Panda BP (2009). "Development of an HPTLC-based diagnostic method for invasive aspergillosis". Biomedical Chromatography. 24 (8): 887–92. doi:10.1002/bmc.1382. PMID 20033890.
Added in 1974, this stated that parents who did not provide medical treatment for a child for religious reasons would not be considered negligent. States were thereafter obliged to include exemptions or lose funding; the wording of the exemptions made clear that they referred to Christian Science. Largely as a result of lobbying by Children's Healthcare is a Legal Duty (active 1983–2017), the government eliminated the HEW regulation in 1983, but 39 states, as well as Guam and the District of Columbia, still had religious exemptions in their civil codes on child abuse and neglect as of February 2015. As of June 2019, the District of Columbia (Washington, D.C.) and 45 states granted religious exemptions, and 15 granted philosophical exemptions, from laws requiring vaccination. Three states (Arizona, Connecticut, and Washington) say that offering a child treatment from a Christian Science practitioner, "in lieu of medical care", is not regarded as neglect. The state of Washington religious exemption as of September 2019 reads: "It is the intent of the legislature that a person who, in good faith, is furnished Christian Science treatment by a duly accredited Christian Science practitioner in lieu of medical care is not considered deprived of medically necessary health care or abandoned." In 1985 128 people were infected with measles, and three died, at Principia College, a Christian Science school in Elsah, Illinois. In 1994, 190 people in six states were infected with measles traced to a child from a Christian Science family in Elsah.
The two-fold purpose of the double-lumen technology was: (i) the aesthetic benefits of silicone gel (contained in the inner lumen) that is enclosed within the outer lumen, which is filled with saline solution; and (ii) a breast prosthesis whose volume is post-operatively adjustable. In surgical practise, the double-lumen prosthetic breast is used primarily in reconstructive surgery of the breasts.
Sources: en.wikipedia.org
There are three distinct types of muscle: skeletal muscle, cardiac or heart muscle, and smooth (non-striated) muscle. Muscles provide strength, balance, posture, movement, and heat for the body to keep warm. There are more than 600 muscles in an adult male human body. A kind of elastic tissue makes up each muscle, which consists of thousands, or tens of thousands, of small muscle fibers. Each fiber comprises many tiny strands called fibrils, impulses from nerve cells control the contraction of each muscle fiber.
However, production climbed markedly when another cigarette-making machine was developed in the 1880s by James Albert Bonsack, which vastly increased the productivity of cigarette companies, which went from making about 40,000 hand-rolled cigarettes daily to around 4 million. At the time, these imported cigarettes from the United States had significant sales among British smokers. In the English-speaking world, the use of tobacco in cigarette form became increasingly widespread during and after the Crimean War, when British soldiers began emulating their Ottoman Turkish comrades and Russian enemies, who had begun rolling and smoking tobacco in strips of old newspaper for lack of proper cigar-rolling leaf. This was helped by the development of tobaccos suitable for cigarette use, and by the development of the Egyptian cigarette export industry.
Many metals such as the alkali metals react directly with the electronegative halogens gases to form salts. Solid salts can form upon evaporation of solvent from their solutions once the solution is supersaturated and the solid compound nucleates. This process occurs widely in nature and is the means of formation of the evaporite minerals. Insoluble salts can be precipitated by mixing two solutions, one containing the cation and one containing the anion. Because all solutions are electrically neutral, the two solutions mixed must also contain counterions of the opposite charges. To ensure that these do not contaminate the precipitated salt, it is important to ensure they do not also precipitate. If the two solutions have hydrogen ions and hydroxide ions as the counterions, they will react with one another in what is called an acid–base reaction or a neutralization reaction to form water. Alternately the counterions can be chosen to ensure that even when combined into a single solution they will remain soluble as spectator ions. If the solvent is water in either the evaporation or precipitation method of formation, in many cases the ionic crystal formed also includes water of crystallization, so the product is known as a hydrate, and can have very different chemical properties compared to the anhydrous material. Molten salts will solidify on cooling to below their freezing point. This is sometimes used for the solid-state synthesis of complex salts from solid reactants, which are first melted together.
Discovered in 1913 and classified as a historical monument in 1916, this wall was in the cellar of a house. Some archaeologists of the time thought they had discovered the rampart that Crinas, a wealthy doctor from Marseilles living in Rome, had built at his own expense in the course of the 1st century. This wall is actually older and dates from the 2nd century BC, but nonetheless kept the name. This is the external facing of the rampart, the internal facing having disappeared but being found in the foundations.
Biotin deficiency Carotenemia Essential fatty acid deficiency Folic acid deficiency Hypervitaminosis A Hypovitaminosis A (phrynoderma) Iron deficiency Kwashiorkor Lycopenemia Maple syrup urine disease Marasmus Niacin deficiency (pellagra, vitamin B3 deficiency) Selenium deficiency Vitamin B1 deficiency (beriberi, thiamine deficiency) Vitamin B12 deficiency (cyanocobalamin deficiency) Vitamin B2 deficiency (ariboflavinosis, riboflavin deficiency) Vitamin B6 deficiency (pyridoxine deficiency) Vitamin B6 excess (pyridoxine excess) Vitamin C deficiency (scurvy) Vitamin K deficiency Zinc deficiency
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.
The fragment contains an actin-binding motif, and cell-free experiments show that it can interact with monomeric actin. That observation is the basis for interest in cell migration and repair processes. Effects reported in animals are not established for humans.
Purity is usually stated by the supplier rather than fixed by a pharmacopoeial monograph, and typical listings report a percentage from reverse-phase HPLC. Independent verification is uncommon. Because no single accepted specification exists, comparisons between lots and between suppliers are difficult.
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.